课题基金 / 基金详情

Investigating the ability of B cells to cross-prime cytotoxic killer T cells

Investigating the ability of B cells to cross-prime cytotoxic killer T cells
研究 B 细胞交叉引发细胞毒性杀伤 T 细胞的能力
批准号:
193195
负责人:
Macauley Matthew S
金额:
$10.93万
依托单位国家:
加拿大
项目类别:
Fellowship Programs
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-10-01 至 2012-10-01

项目摘要

项目成果

Macauley Matthew S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Professional antigen presenting cells are comprised of dendritic cells (DCs), macrophages and B cells. All three of these cell types have the ability to efficiently engage T cells, however, they differ in their ability to acquire antigen and process it in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding CD33 as a Genetic Susceptibility Factor in Alzheimer's Disease
  • 批准号:
    498927
  • 项目类别:
    Operating Grants
  • 资助金额:
    $3.64万
  • 财政年份:
    2023
  • 负责人:
    Macauley Matthew S
  • 依托单位:
Understanding CD33 as a Genetic Susceptibility Factor in Alzheimer's Disease
  • 批准号:
    488668
  • 项目类别:
    Operating Grants
  • 资助金额:
    $79.97万
  • 财政年份:
    2023
  • 负责人:
    Macauley Matthew S
  • 依托单位:
Programmed Glycosylation Changes in Controlling the Germinal Center
  • 批准号:
    462807
  • 项目类别:
    Operating Grants
  • 资助金额:
    $62.7万
  • 财政年份:
    2022
  • 负责人:
    Macauley Matthew S
  • 依托单位:
Canada Research Chair - Tier 2
  • 批准号:
    481073
  • 项目类别:
  • 资助金额:
    $36.43万
  • 财政年份:
    2022
  • 负责人:
    Macauley Matthew S
  • 依托单位:
海外基金